Brief: Orion And Criceto Announce License Agreement For Aporon
25/04/2025 07:11
April 25 (Reuters) - Orion Oyj ORNBV.HE: ORION AND CRICETO ANNOUNCE A LICENSE AGREEMENT FOR APORON®, AN INNOVATIVE APOMORPHINE SPRAY TO TREAT OFF EPISODES IN PARKINSON’S DISEASE Source text: ID:nGNE6GM9Wg Further company coverage: ORNBV.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))